An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)-Reference-Cited by-同舟云学术

An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)

Published:2022-04 Issue: Volume:105 Page:108536
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Elahi Reza,Karami Parsa,Heidary Amir Hossein,Esmaeilzadeh Abdolreza

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference270 articles.

1. Immunobiology and immunotherapy of COVID-19: A clinically updated overview;Esmaeilzadeh;J. Cell. Physiol.,2021

2. The outlook for diagnostic purposes of the 2019-novel coronavirus disease;Tahmasebi;J. Cell. Physiol.,2020

3. The epidemiology, diagnosis and treatment of COVID-19;Zhai;Int. J. Antimicrob. Agents,2020

4. Early fibroproliferative signs on high-resolution CT are associated with mortality in COVID-19 pneumonia patients with ARDS: a retrospective study;Zeng;Therapeut. Adv. Chronic Dis.,2021

5. Interstitial lung disease at high resolution CT after SARS-CoV-2-related acute respiratory distress syndrome according to pulmonary segmental anatomy;Baratella;J. o Clin. Med.,2021

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematological Conditions Associated with COVID-19: Pathophysiology, Clinical Manifestations, and Therapeutic Approaches;European Journal of Medical and Health Research;2024-09-01

2. High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection;Frontiers in Immunology;2024-04-17

3. Evaluation of interleukin‐1 and interleukin‐6 receptor antagonists in a murine model of acute lung injury;Experimental Physiology;2024-04-09

4. Effect of anti-COVID-19 drugs on patients with cancer;European Journal of Medicinal Chemistry;2024-03

5. Agranulocytosis and secondary infection related to JAK inhibitors and IL-6 receptor blockers: a disproportionality analysis using the US Food and drug administration adverse event reporting system;Frontiers in Pharmacology;2024-01-09